NEW YORK (GenomeWeb News) — UK-based synthetic polymer company Chromatide said today that it has received an undisclosed second round of financing from Enterprise Ventures and Alliance Fund Managers, both of which invested in it in 2007.

Chromatide, which plans to use the money to continue expanding its IP portfolio, said that since the first investment it has "successfully delivered on a range of technical and commercial" milestones.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.